Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Positvel Controlled, Multicenter Study of Effects of Telitacicept vs Cyclophosphamide on Lupus Realted Interstitial Lung Disease

NCT07077486 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07077486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07077486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Positvel Controlled, Multicenter Study of Effects of Telitacicept vs Cyclophosphamide on Lupus Realted Interstitial Lung Disease
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
August 25, 2025
Completion date
March 25, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, lupus or sle, systemic lupus erythematosus